Company Filing History:

4 out of 68

Kyowa Medex Co., Ltd.

patents

1 out of 2,202

The United States of America As Represented by the Secretary of

Years Active: 1992-2020

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10588921 - Drug for the treatment of cholesterol accumulation disorders (2020-03-17),

2. 5888827 - Method for determination of cholesterol in low-density lipoprotein or (1999-03-30),

3. 5888755 - Method of determining the amount of cholesterol in a high-density (1999-03-30),

4. 5736406 - Method of determining the amount of cholesterol in a high-density (1998-04-07),

5. 5691159 - Method of determining the amount of cholesterol in a high-density (1997-11-25),

6. 5120720 - Preparation of lipophile:hydroxypropylcyclodextrin complexes by a method (1992-06-09),

Title: An Insight into the Innovations of Tetsumi Irie

Introduction

Tetsumi Irie, an accomplished inventor based in Kumamoto, Japan, holds six patents that reflect his significant contributions to the field of pharmaceuticals. His groundbreaking work focuses on innovative treatments for cholesterol accumulation disorders, marking notable advancements in medical science and patient care.

Latest Patents

Among Tetsumi Irie’s latest patents is a pharmaceutical composition designed for treating disorders caused by cholesterol storage, such as Niemann-Pick disease and GM1 gangliosidosis. This invention not only addresses lysosomal storage diseases but also introduces a method for screening pharmaceutical compositions utilizing iPS cell strains that replicate the phenotypes of these disorders. Additionally, another notable patent involves the use of hydroxypropyl-γ-cyclodextrin as an active ingredient in a pharmaceutical formulation aimed at treating and preventing lysosomal storage disease. Moreover, he developed a novel method for determining cholesterol levels in high-density lipoprotein (HDL) by using cholesterol esterase and cholesterol oxidase, enabling precise measurements crucial for diagnosing cholesterol-related ailments.

Career Highlights

Tetsumi Irie has made significant strides throughout his career, working with reputable organizations such as Kyowa Medex Co., Ltd. and the United States of America as represented by the Secretary of the. His diverse experiences have greatly contributed to his innovative approach to research and development in the pharmaceutical sector.

Collaborations

Throughout his professional journey, Tetsumi has collaborated with notable individuals, including colleagues like Eiko Shutoh and Hiroyuki Sugiuchi. These collaborations have likely enriched his research endeavors and contributed to the success of his patents.

Conclusion

Tetsumi Irie's inventive spirit and dedication to overcoming medical challenges through his patents showcase the impact of his work in addressing crucial health issues. His innovative approaches in treating cholesterol accumulation disorders reinforce the importance of research and development in pharmaceuticals. As he continues to advance the field, the influence of his contributions will undoubtedly resonate within the medical community.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.